These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1704666)
1. [Interferon and its use for treating hairy cell leukemia]. Markov V Vutr Boles; 1990; 29(3):34-40. PubMed ID: 1704666 [No Abstract] [Full Text] [Related]
2. [Interferons and interferon therapy]. Strander H Nord Med; 1992; 107(3):70-1. PubMed ID: 1372403 [No Abstract] [Full Text] [Related]
4. The biology of hairy cell leukemia. A study of the practical aspects of interferon-treatment, its mechanism of action and on the pathogenesis of anemia. Nielsen B APMIS Suppl; 1995; 52():1-39. PubMed ID: 7576791 [No Abstract] [Full Text] [Related]
5. [Hairy-cell leukemia as a model for studying the effects of interferon on the immune system]. Semenzato G; Trentin L; Bulian P; Agostini C; Chisesi T; Pizzolo G Haematologica; 1990; 75 Suppl 4():10-9. PubMed ID: 1705910 [No Abstract] [Full Text] [Related]
6. Immunogenicity of different types of interferons in the treatment of hairy-cell leukemia. von Wussow P; Freund M; Dahle S; Jakschies D; Poliwode H; Deicher H N Engl J Med; 1988 Nov; 319(18):1226-7. PubMed ID: 2459619 [No Abstract] [Full Text] [Related]
7. [Therapeutic aspects of hairy cell leukemia]. Rosa F; Casciaro S; Gatti AM; Boccaccio P; Ghio R Recenti Prog Med; 1989 Jan; 80(1):37-44. PubMed ID: 2469113 [TBL] [Abstract][Full Text] [Related]
9. Interferon therapy in cancer: from imaginon to interferon. Goldstein D; Laszlo J Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950 [No Abstract] [Full Text] [Related]
10. Biotherapy with interferon in hematologic malignancies. Roth MS; Foon KA Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569 [No Abstract] [Full Text] [Related]
11. Recent advances in the treatment of hairy-cell leukemia. Golomb HM; Ratain MJ N Engl J Med; 1987 Apr; 316(14):870-2. PubMed ID: 2434851 [No Abstract] [Full Text] [Related]
12. [Differentiation of human malignant myeloid and lymphoid cells]. Degos L Nouv Rev Fr Hematol (1978); 1987; 29(1):37-41. PubMed ID: 2438644 [TBL] [Abstract][Full Text] [Related]
13. [Antineoplastic effects of interferons]. Shimoyama M Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409 [No Abstract] [Full Text] [Related]
14. [Interferons. Basic principles and use in clinic and general practice]. Hündgen M; von Eick H Med Monatsschr Pharm; 1991 Jun; 14(6):164-73. PubMed ID: 1714536 [No Abstract] [Full Text] [Related]
15. [Interferon and hairy cell leukemia]. Castaigne S; Floch M; Montaron B Soins; 1986 Aug; (483-484):9-10, 12. PubMed ID: 2430339 [No Abstract] [Full Text] [Related]
16. Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia. Arun B; Curti BD; Longo DL; Stevens D; Alvord WG; Gause BL; Watson T; Kopp WC; Janik JE Cancer J Sci Am; 2000; 6(1):21-4. PubMed ID: 10696734 [TBL] [Abstract][Full Text] [Related]
17. Interferon. Hood LE Am J Nurs; 1987 Apr; 87(4):459-65. PubMed ID: 2436479 [No Abstract] [Full Text] [Related]
18. [Interferon in the treatment of hairy cell leukemia]. Deptała A Acta Haematol Pol; 1989; 20(1):86-92. PubMed ID: 2515708 [No Abstract] [Full Text] [Related]
19. Development and mechanisms of interferon resistance. Kloke O; Niederle N Cancer Treat Rev; 1990 Dec; 17 Suppl A():81-8. PubMed ID: 1709389 [No Abstract] [Full Text] [Related]
20. Sequential treatment of hairy cell leukemia: a new role for interferon. Golomb HM; Ratain MJ; Vardiman JW Important Adv Oncol; 1986; ():311-21. PubMed ID: 2454218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]